Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Aquivia Health vs Contour Health

Aquivia Health
Graded #81

Higher grade

vs+5.400000000000006
Contour Health
Graded #177

Lower grade

The verdict

Aquivia Health takes it — 72.2/100 to 66.8/100.

Aquivia Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Aquivia Health is a clinician-led, self-pay telehealth platform offering compounded GLP-1 therapy with the option to step up to branded Ozempic or Zepbound — an unusual side-by-side most compounded…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueAquivia Health +21
86
65
Dose & formulationAquivia Health +21
85
64
Clinical oversightContour Health +21
64
85
Labs & monitoringEven
53
53
FulfillmentAquivia Health +1
71
70
Contract termsEven
55
55
Aquivia Health · left barContour Health · right bar

The numbers

MetricAquivia HealthContour Health
WeighScore72.2/10066.8/100
GradeCC
Scorecard rank#81#177
Semaglutide$149/mo$160/mo (starting dose, compounded)
Tirzepatide$179/mo$300/mo (starting dose, compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyInjection only
Aquivia Health

Graded #81 · C

Strengths

  • Clinical care provided by Open Loop Healthcare Partners, PC — a reused, verified MSO network
  • Named leadership: Steven Bishop MD (CMO), Phillip Gray PharmD (Chief Pharmacist), Tom Foster (President)
  • Itemized public pricing: compounded semaglutide $149/mo, tirzepatide $179/mo, Ozempic $1,299, Zepbound $1,399
  • Both compounded and branded GLP-1s offered side by side — unusual for a compounded provider
  • Self-pay model with no insurance required and no separate consultation fee

Where it loses points

  • No public list of states served — you must complete intake to learn if your state qualifies
  • No named 503A compounding pharmacy partner, limiting licensure verification
  • No LegitScript, PCAB, or BBB trust badges visible
  • Brand confusion: site schema names 'CatalystMD' while the customer-facing brand is Aquivia Health
  • FDA has issued this company a warning letter; the letter is public in FDA's warning-letter database
Contour Health

Graded #177 · C

Strengths

  • Free medical consultation — no charge to talk with a provider before starting
  • Pay-per-vial pricing with no long-term subscription commitment required to participate
  • Names its compounding pharmacy partner (Strive Pharmacy, 503A accredited) — a real transparency signal
  • LegitScript badge links to a genuine, working LegitScript verification checker for the domain
  • Board-certified Medical Director and named nurse-practitioner care team, not anonymous providers

Where it loses points

  • State availability list is not published — Terms of Service only says "certain states"
  • All product purchases are non-refundable per Terms of Service
  • Compounded injectable only — no oral option, no brand-name Wegovy/Zepbound/Ozempic/Mounjaro
  • Terms of Service also describe an optional subscription tier with a 3-month minimum, despite marketing emphasizing "no subscriptions"
  • No insurance, Medicare, or Medicaid accepted — cash-pay or HSA/FSA only

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard